ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

Amineptine

HCID 34870
ノート反応
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
57574-09-1
標準SMILES
O=C(O)CCCCCCNC1c2ccccc2CCc2ccccc21
InChIKey
ONNOFKFOZAJDHT-UHFFFAOYSA-N
分子式
C22H27NO2
平均分子量
337.5 g/mol
単同位体質量
337.2041791

概要

Amineptine is a carbocyclic fatty acid that is 5-aminoheptanoic acid in which one of the hydrogens attached to the nitrogen is replaced by a 10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-yl group. A tricyclic antidepressant, it was never approved in the US and was withdrawn from the French market in 1999 due to concerns over abuse, dependence and severe acne. It has a role as an antidepressant and a dopamine uptake inhibitor. It is an amino acid, a carbocyclic fatty acid, a carbotricyclic compound and a secondary amino compound. It derives from a hydride of a dibenzo[a,d][7]annulene.

名称と識別子

優先名称
Amineptine
IUPAC
7-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylamino)heptanoic acid

名称と別名

AmineptineAmineptin57574-09-1AmineptinoAmineptinumamineptinaDTXSID104883127T1I13L6G7-((10,11-Dihydro-5H-dibenzo(a,d)cyclohepten-5-yl)amino)heptanoic acid7-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylamino)heptanoic acidDTXCID4028757CHEBI:32499
名称をさらに表示
7-[(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic Acid7-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylamino)heptanoic acid10,11-dihydrodibenzo(a,d)cyclohept-5-enyl-7-aminoheptanoic acidRefChem:111994N06AA19260-818-0Amineptine [INN]Amineptine (INN)

データベース識別子

CAS
57574-09-1
PubChem CID
34870
DTXSID
DTXSID1048831
ChEMBL
CHEMBL418995
ChEBI
CHEBI:32499
UNII
27T1I13L6G
EC Number
260-818-0
Nikkaji
J11.860E

物性

構造計算による物性

XLogP
2.1
極性表面積
49.3 Ų
水素結合供与体数
2
水素結合受容体数
3
回転可能結合数
8
重原子数
25
形式電荷
0
複雑度
387

実験および物理化学的性質

Drugs · 2 件

DEA Schedule I Controlled Substance -> Stimulants

Pharmaceuticals -> Listed in ZINC15

Human DrugsPharmaceuticals
Melting Point226-230

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

危険有害性情報

Regulatory InformationDEA schedule I controlled substance

毒性情報

Drug Induced Liver Injury · 6 件

Drug Induced Liver Injury Rank (DILIrank 2.0)

Amineptine

vMost-DILI-concern

8

Withdrawn

DOI:10.1016/j.drudis.2016.02.015

化学と産業

薬理情報

ATC Code · 2 件

N - Nervous system

QN - Nervous system

PharmacodynamicsAmineptine is an atypical tricyclic antidepressant.
Mechanism of ActionAmineptine selectively inhibits the reuptake of dopamine and to a lesser extent norepinephrine, thus exerting a powerful and fast-acting antidepressant effect.
Biological Half-Life48 minutes for the parent drug and 2.5 hours for the metabolites.
Metabolism/MetabolitesHepatic.
MeSH Pharmacological Classification · 2 件

Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system.

A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents).

用途と製造

Use ClassificationPharmaceuticals

関連反応

0 件
反応記録を作成

現在のフィルター条件では反応記録がありません。

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート